Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Qarlbo Biodiversity Signs First-Ever Voluntary Biodiversity Credit Agreement in the U.S.
-
Broadridge Announces New Patent on Large Language Model Orchestration of Machine Learning Agents
-
Falcon Oil & Gas Ltd. - Beetaloo Operational Update – Stimulation Campaign & Remaining Shenandoah South Pilot Project
-
Voting Rights and Shares Capital of the Company
-
Falcon Oil & Gas Ltd. - Beetaloo Operational Update – Stimulation Campaign & Remaining Shenandoah South Pilot Project
-
Changes to the Agenda and Draft Resolutions of the Annual General Meeting of AS Ekspress Grupp on 23 May 2025
-
Q1 2025 Financial Results
-
Report on Payments to Governments
-
From "Manufacturing Overseas" to "Cultural Voyage": STARAY Breaks Boundaries
-
From "Manufacturing Overseas" to "Cultural Voyage": STARAY Breaks Boundaries
-
Green Notes of AKROPOLIS GROUP, UAB are planned to be listed on Euronext Dublin and Nasdaq Vilnius stock exchanges
-
The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market decline
-
Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
-
SolarEast Launches Global R290 Heat Pump System to Advance Climate Goals and Energy Efficiency
-
"Tea for Harmony - Yaji Cultural Salon" and "Jiangxi Day" Promotion Event Held in Morocco
-
Immutable Brings Gaming to Institutional Capital at Goldman Sachs' Asia Financial Technology Conference
-
"Tea for Harmony - Yaji Cultural Salon" and "Jiangxi Day" Promotion Event Held in Morocco
-
MaaT Pharma to Hold Annual General Meeting on June 20, 2025
-
FLSmidth & Co. A/S: Better-than-expected Q1 2025, with a strong financial performance in Mining driving an upgraded full-year guidance
-
Bouygues: First-quarter 2025 results
-
FLSmidth & Co. A/S: Better-than-expected Q1 2025, with a strong financial performance in Mining driving an upgraded full-year guidance
-
Vitura: Activity at end-March 2025
-
Alstom S.A: FY 2024/25: Alstom delivers solid profit and cash. Medium-term ambitions confirmed.
-
Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial
-
Atos Group: new strategic and transformation plan “Genesis” to leverage core strengths and restore sustainable profitable growth. Cash generation and disciplined capital allocation as key drivers
-
GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California
-
ABN AMRO Bank posts net profit of EUR 619 million in Q1 2025
-
Results of the Ordinary Shareholders' Meeting of Solvac
-
Transaction in Own Shares
-
FLSmidth raises its full-year 2025 financial guidance
-
Seeds of Bliss Earns Recognition as Best Holistic Healing Practice for Personal Transformation in Greece of 2025
-
Evelyn Chao and PM Ready: Pioneering Youth Empowerment with Project Management
-
Indigo Collective Integrates Cutting-Edge Technology and Sustainable Practices to Transform the Beauty Industry
-
Bekaert - Update on the Share Buyback Program
-
Cronofy secures £15m BGF investment to supercharge growth
-
More Uncertain Times Driving Positive Vibe for Insurance
-
Love You Well LED Mask by Aussie Mum Wins "Best In-Home Beauty LED Light Therapy Mask in Australia 2025
-
Teddy Group Selects Centric Market Intelligence to Power Market Expansion with Competitor Benchmarking and Data-Driven Decision-Making
-
Scarlett Gasque Selects Centric PLM to Power Product Expansion and Digital Growth
-
TeacherAI.app: Awarded Best AI Tool for Teachers and Educators in the US for 2025
-
Avance Clinical Honored with Frost & Sullivan's 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services
-
Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS
-
Start of Day Message
-
NORBIT - Results for the first quarter 2025
-
Nyxoah Reports First Quarter Financial and Operating Results
-
INTERIM REPORT OF MARIMEKKO CORPORATION, 1 January–31 March 2025: Marimekko’s net sales in the first quarter grew and operating profit was at a good level
-
Subsea 7 S.A. – Ex-dividend NOK 6.50 today
-
Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting
-
Trading update Q1 2025: steady first quarter performance and full-year outlook confirmed
-
Bekaert - Trading update for the first three months of 2025

